Comi, Giancarlo <br/><br/>
Benefit-Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis.  [electronic resource] 

 -  Drugs  Oct 2017 
 - 1755-1768 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1179-1950 
<br/><br/><label>Standard No.: </label>10.1007/s40265-017-0814-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Fingolimod Hydrochloride--administration & dosage<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Multiple Sclerosis--diagnosis<br/>Natalizumab--administration & dosage<br/>Receptors, Lysosphingolipid--metabolism<br/>Risk Assessment